Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001621899-14-000006
Filing Date
2014-10-17
Accepted
2014-10-17 17:05:06
Documents
2
Period of Report
2014-10-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1503
2 EDGAR SUPPORTING DOCUMENT bryan.txt EX-24 3340
  Complete submission text file 0001621899-14-000006.txt   6134
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Riggsbee Richard Bryan (Reporting) CIK: 0001621899 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 141162404